U.S. Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables, Services), By Sample Type, By Technology, By Application By End-use, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Research Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 Segment Scope
                       1.1.2 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database:
                       1.3.2 Gvr’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information Or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                            1.6.1.1 Approach: Commodity Flow Approach
                   1.7 Research Assumptions
                   1.8 List Of Secondary Sources
                   1.9 List Of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective 1
                       1.10.2 Objective 2
                       1.10.3 Objective 3
                       1.10.4 Objective 4
Chapter 2 Executive Summary
                   2.1 Market Snapshot
                   2.2 Segment Snapshot (1/3)
                   2.3 Segment Snapshot (2/3)
                   2.4 Segment Snapshot (3/3)
                   2.5 Competitive Landscape Snapshot
Chapter 3 U.S. Infectious Respiratory Disease Diagnostics Market Variables, Trends, And Scope
                   3.1 Parent Market Outlook
                   3.2 Penetration And Growth Prospect Mapping
                   3.3 Market Driver Analysis
                       3.3.1 High Prevalence Of Infectious Respiratory Diseases In U.S.
                       3.3.2 Technological Advancement In Respiratory Disease Testing
                       3.3.3 Rising R&D Investments In Respiratory Disease Testing
                   3.4 Market Restraint Analysis
                       3.4.1 High Prices Of Diagnostic Products
                       3.4.2 Presence Of Ambiguous Regulatory Framework
                   3.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
                   3.6 Industry Analysis - Porter’s
                       3.6.1 Regulatory Framework
                       3.6.2 Reimbursement Scenario
Chapter 4 U.S. Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By Product Type, 2018 - 2030 (USD Million)
                   4.1 Definitions And Scope
                   4.2 U.S. Infectious Respiratory Disease Diagnostics Market: Product Type Movement Analysis
                   4.3 Instruments
                       4.3.1 Instruments Market, 2018 - 2030 (USD Million)
                       4.3.2 Imaging Tests
                            4.3.2.1 Imaging Tests Market, 2018 - 2030 (USD Million)
                       4.3.3 Respiratory Measurement Devices
                            4.3.3.1 Respiratory Measurement Devices Market, 2018 - 2030 (USD Million)
                       4.3.4 Other Instruments
                            4.3.4.1 Other Instruments Market, 2018 - 2030 (USD Million)
                   4.4 Consumables
                       4.4.1 Consumables Market, 2018 - 2030 (USD Million)
                   4.5 Services
                       4.5.1 Services Market, 2018 - 2030 (USD Million)
Chapter 5 U.S. Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By Sample Type, 2018 - 2030 (USD Million)
                   5.1 Definitions & Scope
                   5.2 U.S. Infectious Respiratory Disease Diagnostics Market: Sample Type Movement Analysis
                   5.3 Saliva
                       5.3.1 Saliva Market, 2018 - 2030 (USD Million)
                   5.4 Nasopharyngeal Swabs (Nps)
                       5.4.1 Nasopharyngeal Swabs (Nps) Market, 2018 - 2030 (USD Million)
                   5.5 Anterior Nasal Region
                       5.5.1 Anterior Nasal Region Market, 2018 - 2030 (USD Million)
                   5.6 Blood
                       5.6.1 Blood Market, 2018 - 2030 (USD Million)
                   5.7 Others
                       5.7.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 U.S. Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)
                   6.1 Definitions And Scope
                   6.2 U.S. Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
                   6.3 Immunoassay
                       6.3.1 Immunoassay Market, 2018 - 2030 (USD Million)
                   6.4 Molecular Diagnostics
                       6.4.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million)
                   6.5 Microbiology
                       6.5.1 Microbiology Market, 2018 - 2030 (USD Million)
                   6.6 Other Technologies
                       6.6.1 Other Technologies Market, 2018 - 2030 (USD Million)
Chapter 7 U.S. Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million) (‘000s)
                   7.1 U.S. Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
                   7.2 Covid-19
                       7.2.1 Covid-19 Market, 2018 - 2030 (USD Million)
                       7.2.2 Covid-19 Market, 2018 - 2030 (Volume ‘000s)
                   7.3 Influenza
                       7.3.1 Influenza Market, 2018 - 2030 (USD Million)
                       7.3.2 Influenza Market, 2018 - 2030 (Volume ‘000s)
                   7.4 Respiratory Syncytial Virus
                       7.4.1 Respiratory Syncytial Virus Market, 2018 - 2030 (USD Million)
                       7.4.2 Respiratory Syncytial Virus Market, 2018 - 2030 (Volume ‘000s)
                   7.5 Tuberculosis
                       7.5.1 Tuberculosis Market, 2018 - 2030 (USD Million)
                       7.5.2 Tuberculosis Market, 2018 - 2030 (Volume ‘000s)
                   7.6 Streptococcus Testing
                       7.6.1 Streptococcus Testing Market, 2018 - 2030 (USD Million)
                       7.6.2 Streptococcus Testing Market, 2018 - 2030 (Volume ‘000s)
                   7.7 Other Respiratory Disease Testing
                       7.7.1 Other Respiratory Disease Testing Market, 2018 - 2030 (USD Million)
                       7.7.2 Other Respiratory Disease Testing Market, 2018 - 2030 (Volume ‘000s)
Chapter 8 U.S. Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
                   8.1 U.S. Infectious Respiratory Disease Diagnostics Market: End-Use Movement Analysis
                   8.2 Hospitals
                       8.2.1 Hospitals Market, 2018 - 2030 (USD Million)
                   8.3 Diagnostic Laboratories
                       8.3.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
                   8.4 Physician Offices
                       8.4.1 Physician Offices Market, 2018 - 2030 (USD Million)
                   8.5 Other End Users
                       8.5.1 Other End-Users Market, 2018 - 2030 (USD Million)
Chapter 9 U.S. Infectious Respiratory Disease Diagnostics Market: Competitive Analysis
                   9.1 Participants’ Overview
                   9.2 Financial Performance
                   9.3 Participant Categorization
                       9.3.1 Market Leaders
                            9.3.1.1 U.S. Infectious Respiratory Disease Diagnostics Market Share Analysis, 2022
                       9.3.2 Strategy Mapping
                            9.3.2.1 Expansion
                            9.3.2.2 Acquisition
                            9.3.2.3 Collaborations
                            9.3.2.4 Product/Service Launch
                            9.3.2.5 Partnerships
                            9.3.2.6 Others
                       9.3.3 Vendor Landscape
                            9.3.3.1 List Of Distributors And Channel Partners
                            9.3.3.2 Key Customers
                   9.4 Competitive Dashboard Analysis
                       9.4.1 Private Companies
                            9.4.1.1 List of Emerging Companies/Technology Disruptors/ Innovators
                            9.4.1.2 Regional Network Map include:
                                9.4.1.2.1 Abbott
                                9.4.1.2.2 Koninklijke Philips N.V.
                                9.4.1.2.3 Siemens Healthcare GmbH
                                9.4.1.2.4 BIOMÉRIEUX
                                9.4.1.2.5 Danaher
                                9.4.1.2.6 QIAGEN
                                9.4.1.2.7 BD
                                9.4.1.2.8 F. Hoffmann-La Roche Ltd
                                9.4.1.2.9 Quidel Corporation
                                9.4.1.2.10 Thermo Fisher Scientific, Inc.

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 CPT codes reimbursement of diagnostic tests
Table 4 U.S. infectious respiratory disease diagnostics market by, product type, 2018 - 2030 (USD Million)
Table 5 U.S. infectious respiratory disease diagnostics market by, sample type, 2018 - 2030 (USD Million)
Table 6 U.S. infectious respiratory disease diagnostics market by, technology, 2018 - 2030 (USD Million)
Table 7 U.S. infectious respiratory disease diagnostics market by, application, 2018 - 2030 (USD Million)
Table 8 U.S. infectious respiratory disease diagnostics market by, end-use, 2018 - 2030 (USD Million)
Table 9 Participant’s overview
Table 10 Financial performance
Table 11 Key companies undergoing expansions
Table 12 Key companies undergoing acquisitions
Table 13 Key companies undergoing collaborations
Table 14 Key companies launching new products/services
Table 15 Key companies undergoing partnerships
Table 16 Key companies undertaking other strategies

List of Figures

Fig. 1 U.S. Infectious Respiratory Disease Diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot (By product & sample type)
Fig. 11 Segment snapshot (By technology type & end-use type)
Fig. 12 Segment snapshot (By application)
Fig. 13 Competitive landscape snapshot
Fig. 14 Penetration and growth prospect mapping
Fig. 15 U.S. infectious respiratory disease diagnostics market driver impact
Fig. 16 Number of new tuberculosis cases from 2018-2021, in the U. S.
Fig. 17 Incidence rate trend of tuberculosis from 2018-2021
Fig. 18 U.S. infectious respiratory disease diagnostics market restraint impact
Fig. 19 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 20 Porter’s Five Forces Analysis
Fig. 21 U.S. healthcare reimbursement and financing structure
Fig. 22 U.S. infectious respiratory disease diagnostics product type outlook: Key takeaways
Fig. 23 Infectious respiratory disease diagnostics market: Product type movement analysis (USD Million)
Fig. 24 Instruments market, 2018 - 2030 (USD Million)
Fig. 25 Imaging tests market, 2018 - 2030 (USD Million)
Fig. 26 Respiratory measurement devices market, 2018 - 2030 (USD Million)
Fig. 27 Other instruments market, 2018 - 2030 (USD Million)
Fig. 28 Consumables market, 2018 - 2030 (USD Million)
Fig. 29 Services market, 2018 - 2030 (USD Million)
Fig. 30 U.S. Infectious respiratory disease diagnostics Sample type outlook: Key takeaways
Fig. 31 U.S. infectious respiratory disease diagnostics market: Sample type movement analysis (USD Million)
Fig. 32 Saliva market, 2018 - 2030 (USD Million)
Fig. 33 Nasopharyngeal swabs (NPS) market, 2018 - 2030 (USD Million)
Fig. 34 Anterior Nasal Region market, 2018 - 2030 (USD Million)
Fig. 35 Blood market, 2018 - 2030 (USD Million)
Fig. 36 Others market, 2018 - 2030 (USD Million)
Fig. 37 U.S. infectious respiratory disease diagnostics technology outlook: Key takeaways
Fig. 38 U.S. infectious respiratory disease diagnostics market: Technology movement analysis (USD Million)
Fig. 39 Immunoassay market, 2018 - 2030 (USD Million)
Fig. 40 Molecular diagnostics market, 2018 - 2030 (USD Million)
Fig. 41 Microbiology market, 2018 - 2030 (USD Million)
Fig. 42 Other technologies market, 2018 - 2030 (USD Million)
Fig. 43 U.S. infectious respiratory disease diagnostics application outlook: Key takeaways
Fig. 44 U.S. infectious respiratory disease diagnostics application outlook: Key takeaways (Volume 000)
Fig. 45 U.S. infectious respiratory disease diagnostics market: Application movement analysis (USD Million)
Fig. 46 U.S. infectious respiratory disease diagnostics market: Application movement analysis (Volume, ‘000s)
Fig. 47 COVID-19 market, 2018 - 2030 (USD Million)
Fig. 48 COVID-19 market, 2018 - 2030 (Volume ‘000s)
Fig. 49 Influenza market, 2018 - 2030 (USD Million)
Fig. 50 Influenza market, 2018 - 2030 (Volume ‘000s)
Fig. 51 Respiratory syncytial virus market, 2018 - 2030 (USD Million)
Fig. 52 Respiratory syncytial virus market, 2018 - 2030 (Volume ‘000s)
Fig. 53 Tuberculosis market, 2018 - 2030 (USD Million)
Fig. 54 Tuberculosis market, 2018 - 2030 (Volume ‘000s)
Fig. 55 Streptococcus testing market, 2018 - 2030 (USD Million)
Fig. 56 Streptococcus testing market, 2018 - 2030 (Volume ‘000s)
Fig. 57 Other respiratory disease testing market, 2018 - 2030 (USD Million)
Fig. 58 Other respiratory disease testing market, 2018 - 2030 (Volume ‘000s)
Fig. 59 U.S. Infectious respiratory disease diagnostics end-use outlook: Key takeaways
Fig. 60 U.S. infectious respiratory disease diagnostics market: End-use movement analysis (USD Million)
Fig. 61 Hospitals market, 2018 - 2030 (USD Million)
Fig. 62 Diagnostic laboratories market, 2018 - 2030 (USD Million)
Fig. 63 Physician offices market, 2018 - 2030 (USD Million)
Fig. 64 Other end-users’ market, 2018 - 2030 (USD Million)
Fig. 65 Market participant categorization
Fig. 66 U.S. infectious respiratory disease diagnostics market share analysis, 2022
Fig. 67 Strategic framework
Fig. 68 Company market position analysis
Fig. 69 Regional network map